Global prevalence of onychomycosis in general and special populations: An updated perspective.
Gupta AK, Wang T, Polla Ravi S, Mann A, Bamimore MA.
Mycoses. 2024 Apr;67(4):e13725. doi: 10.1111/myc.13725.
Treatment failures and relapses in onychomycosis: a stubborn clinical problem.
Arrese JE, Piérard GE.
Dermatology. 2003;207(3):255-60. doi: 10.1159/000073086.
New Sources of Resistance to Terbinafine Revealed and Squalene Epoxidase Modelled in the Dermatophyte Fungus Trichophyton interdigitale From Australia.
Mechidi P, Holien J, Grando D, Huynh T, Lawrie AC.
Mycoses. 2024 Sep;67(9):e13795. doi: 10.1111/myc.13795.
Novel Point Mutations in cyp51Acyp51BAspergillus clavatus Isolates.
Abastabar M, Hosseini T, Valadan R, Lagzian M, Haghani I, Aslani N, Badali H, Nouripour-Sisakht S, Nazeri M, Gholami S, Vakili M, Bowyer P, Shokohi T, Hedayati MT.
Microb Drug Resist. 2019 Jun;25(5):652-662. doi: 10.1089/mdr.2018.0300. Epub 2019 Jan 18.
